Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Changes in Resting-State Functional Connectivity and Cognitive-Affective Symptoms in Patients With Post-Concussion Syndrome Treated With N-Acetyl Cysteine.

  • 2024-11-07
  • The Journal of head trauma rehabilitation 40(3)
    • Daniel A Monti
    • Vedaei Faezeh
    • George Zabrecky
    • Mahdi Alizadeh
    • Nancy Wintering
    • Anthony J Bazzan
    • Feroze B Mohamed
    • Andrew B Newberg

Study Design

Type
Randomized Controlled Trial (RCT)
Population
Fifty patients with chronic PCS for at least 3 months post injury
Methods
randomized unblinded clinical trial to receive the antioxidant NAC as a combination of daily oral and weekly intravenous infusions, or assigned to a waitlist control group where they would continue to receive standard of care
Blinding
Open-label
Duration
not stated

Objective

Concussion accounts for more than 80% of people experiencing traumatic brain injury. Acute concussion is associated with characteristic cognitive and functional deficits that may persist for weeks to months. A subgroup of these patients (from 10% to 50%) have persistent symptoms referred to as chronic post-concussion syndrome (PCS). There are limited treatment options for these patients and the pathophysiology is poorly understood, though oxidative stress is thought to be a contributing factor. The purpose of this study was to evaluate whether an antioxidant, N -acetylcysteine (NAC), might be beneficial in patients with PCS.

Setting

Outpatient medicine center.

Participants

Fifty patients with chronic PCS for at least 3 months post injury.

Design

The patients with PCS were enrolled in this randomized unblinded clinical trial to receive the antioxidant NAC as a combination of daily oral and weekly intravenous infusions, or assigned to a waitlist control group where they would continue to receive standard of care.

Main measures

Resting-state functional connectivity (FC) magnetic resonance imaging (rsFC-MRI) was performed pre and post either NAC or the waitlist period along with cognitive, emotional, and sensory symptom assessments.

Results

The results demonstrated significant ( P < .05) improvements in symptoms as determined by the Rivermead Post-Concussion Symptoms Questionnaire, Spielberger State-Trait Anxiety Inventory, and Profile of Mood Scale in the PCS group receiving NAC as compared to patients receiving ongoing standard care. Importantly, there were significant ( P < .01) changes in FC in the NAC group, particularly in networks such as the default mode network, salience network, and executive control network. These changes in FC also correlated with improvements in symptoms.

Conclusions

In patients with chronic PCS, NAC treatment was associated with significant changes in resting state FC and improvement in a variety of symptoms, particularly cognitive and affective symptoms.

Research Insights

  • N-Acetyl Cysteine→Improved Mood

    The results demonstrated significant (P < .05) improvements in symptoms as determined by the ... Profile of Mood Scale in the PCS group receiving NAC as compared to patients receiving ongoing standard care.

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    combination of daily oral and weekly intravenous infusions
  • N-Acetyl Cysteine→Reduced Anxiety

    The results demonstrated significant (P < .05) improvements in symptoms as determined by the ... Spielberger State-Trait Anxiety Inventory ... in the PCS group receiving NAC as compared to patients receiving ongoing standard care.

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    combination of daily oral and weekly intravenous infusions
Back to top